As per this study, the Global Human Chorionic Gonadotropin Market was valued USD XX MN (by revenue) in 2019 and is anticipated to reach USD XX MN by 2026 with a CAGR of XX%.
Human chorionic gonadotropin as HCG is the placental hormone secreted by the placental cells in pregnancy immediately after implantation. HCG stimulates egg secretion during ovulation and also helps to treat infertility in female and increase sperm count in the male population. Presence of HCG is detected in urine or blood sample of pregnant female.
The rising prevalence of infertility among both female and male population is the major driver driving the market growth. Increasing cases with polycystic ovary syndrome, endometriosis, hypogonadism, oligospermia, and other hormonal disorders are further pushing the market demand. Also, changing lifestyle, improper eating habits and increased maternity age are some of the prominent factors boosting the market demand. In addition to this, increasing awareness regarding HCG hormone treatment by medical professionals is likely to upsurge the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis, and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of human chorionic gonadotropin.
The broad human chorionic gonadotropin market has been sub-grouped into type, application, and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Therapeutic Area
- Natural Source Extraction
- Recombinant Technology
- Female Infertility Treatment
- Male Hypogonadism
- Oligospermic Treatment
- Fertility Clinics
- Research Institution
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for human chorionic gonadotropinin North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Human Chorionic Gonadotropin Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the human chorionic gonadotropin market include Bristol Myers Squibb Company, Cigna, Ferring B.V., Fresenius Kabi AG, Lee BioSolutions, Inc., Lupin, Merck & Co., Inc., Sanzyme, Scripps Laboratories and Sun Pharmaceutical Industries Ltd. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.